Rapamycin

From Proteopedia

Jump to: navigation, search

Rapamycin, isolated from the bacterium Streptomyces hygroscopicus, is an immuno-suppressant and anticancer drug[1]. It acts by binding the the mTORC1 protein complex, a kinase that regulates cell growth and metabolism. In the future, it might also be used in treatment of type 2 diabetes[2].

Structure

References

  1. https://en.wikipedia.org/wiki/Sirolimus
  2. https://doi.org/10.3389/fphar.2016.00395
  3. Marz AM, Fabian AK, Kozany C, Bracher A, Hausch F. Large FK506-binding Proteins Shape the Pharmacology of Rapamycin. Mol Cell Biol. 2013 Jan 28. PMID:23358420 doi:http://dx.doi.org/10.1128/MCB.00678-12

Proteopedia Page Contributors and Editors (what is this?)

Karsten Theis

Personal tools